Apple Computer (AAPL) 72.94 +7.48 (+11.4%)
After issuing better than expected Q1 (Dec) guidance on Oct 12, computer hardware maker blows aways the upwardly revised estimates; EPS tops by $0.22 at $0.70 and revenues beat by 11% at $3.49 bln; Management cited the 'fantastic results of iPod;' Company then issues upside guidance for Q2 (Mar): puts EPS at $0.40 and revenues at $2.9 bln, as compared to the Reuters Estimates consensus of $0.33 and $2.749 bln, respectively; Stock has set another 52-week high tonight
Borders Group (BGP) 24.50 +0.76 (+3.2%)
Book retailer guides higher for Q4 (Jan), putting EPS at $1.60-1.62 as compared to the Reuters Estimates consensus of $1.59; The company said consolidated sales, which included Borders stores and Waldenbooks outlets, increased 4.8% to $1.2 bln; Management described the sales at its namesake stores as a 'bit better than expected' during the key holiday period; Stock has been range-bound recently due in part to a miss in Q3 (Oct)
Infineon (IFX) 10.01 -0.01 (-0.1%)
European chip maker warns for Q1 (Dec), saying that revenues and earnings before interest and taxes (EBIT) will be below market expectations; Company cited reduced volumes, lower revenues, and inventory corrections as reasons its various groups underperformed relative to expectations; Competitor STM has weakened some tonight off the news
Pfizer (PFE) 25.78 -0.25 (-1.0%)
Drug giants gets a FDA warning saying that it left out risk information and made unsubstantiated claims in its advertisers for COX-2 inhibitors Bextra and Celebrex; The government agency asked Pfizer to cease the dissemination of the promotional materials; This action isn't very surprising considering the recent study linking Celebrex to higher risk of cardiovascular events - similar to recent studies for Merck's (MRK) Vioxx; Pfizer has already pulled advertising of the drug
O Clubeinvest.com informa que nenhuma da informação
aqui facultada deverá ser entendida como conselho ou recomendação
de qualquer tipo de transacção ou investimento.
